GDTC LongLooks like a decent trade with 2+ r/r, coming from a low base can go long after a period of accumulation
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.20 USD
−3.08 M USD
0.00 USD
4.73 M
About CytoMed Therapeutics Limited
Sector
Industry
CEO
Wee Kiat Tan
Website
Headquarters
Singapore
Founded
2018
ISIN
SGXZ17669631
FIGI
BBG01BM32FR8
CytoMed Therapeutics Ltd. is a biopharmaceutical company, which engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy, and undertaking the research and development of immune cell and stem cell-based therapy. It operates through the Malaysia and Singapore geographical segments. The company was founded by Chee Kong Choo on March 9, 2018 and is headquartered in Singapore.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GDTC is 2.17 USD — it has decreased by −4.50% in the past 24 hours. Watch CytoMed Therapeutics Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CytoMed Therapeutics Limited stocks are traded under the ticker GDTC.
GDTC stock has fallen by −7.22% compared to the previous week, the month change is a 5.61% rise, over the last year CytoMed Therapeutics Limited has showed a −43.78% decrease.
We've gathered analysts' opinions on CytoMed Therapeutics Limited future price: according to them, GDTC price has a max estimate of 5.00 USD and a min estimate of 5.00 USD. Watch GDTC chart and read a more detailed CytoMed Therapeutics Limited stock forecast: see what analysts think of CytoMed Therapeutics Limited and suggest that you do with its stocks.
GDTC reached its all-time high on Jul 11, 2023 with the price of 9.25 USD, and its all-time low was 1.20 USD and was reached on Sep 25, 2024. View more price dynamics on GDTC chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GDTC stock is 37.69% volatile and has beta coefficient of −0.35. Track CytoMed Therapeutics Limited stock price on the chart and check out the list of the most volatile stocks — is CytoMed Therapeutics Limited there?
Today CytoMed Therapeutics Limited has the market capitalization of 24.46 M, it has decreased by −7.07% over the last week.
Yes, you can track CytoMed Therapeutics Limited financials in yearly and quarterly reports right on TradingView.
CytoMed Therapeutics Limited is going to release the next earnings report on May 5, 2025. Keep track of upcoming events with our Earnings Calendar.
GDTC net income for the last half-year is −807.96 K USD, while the previous report showed −1.46 M USD of net income which accounts for 44.77% change. Track more CytoMed Therapeutics Limited financial stats to get the full picture.
No, GDTC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 16, 2024, the company has 34.00 employees. See our rating of the largest employees — is CytoMed Therapeutics Limited on this list?
Like other stocks, GDTC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CytoMed Therapeutics Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CytoMed Therapeutics Limited technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CytoMed Therapeutics Limited stock shows the neutral signal. See more of CytoMed Therapeutics Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.